Each year, 10 million severe stroke patients are picked up by ambulances around the world. Half of these stroke patients that can be treated with endovascular treatment, but are brought to hospitals that do not have endovascular treatment. This results in an average delay of endovascular treatment of 90 minutes, which leads to seriously worsened disease outcomes and a larger burden on society.
With StrokePointer from trianect, we combine brain activity measurement and artificial intelligence to detect these treatable stroke patients in the ambulance and bring them directly to their best treatment. This saves time and time = brain.
Dr. Wouter Potters
Dr. Jonathan Coutinho
Dr. Henk Marquering
Business Developer IXA
Amsterdam Science & Innovation Award
First clinical trial results
Do you want to join our mission to improve acute stroke care?
Then connect with us at firstname.lastname@example.org